NRX Pharmaceuticals (NRXP) Prepaid Assets (2017 - 2026)
NRX Pharmaceuticals' (NRXP) quarterly Prepaid Assets came in at $467000.0 in Q1 2026, down 72.66% year-on-year from $1.7 million in Q1 2025, and up 63.29% on a QoQ basis from $286000.0 in Q4 2025.
NRX Pharmaceuticals (NRXP) Prepaid Assets (2017 - 2026) Analysis & Trends
NRX Pharmaceuticals (NRXP) has 10 years of Prepaid Assets data on file, last reported at $467000.0 in Q1 2026.
- On a quarterly basis, Prepaid Assets fell 72.66% year-over-year to $467000.0 in Q1 2026; TTM through Mar 2026 was $467000.0, a 72.66% decrease from a year earlier, with the FY2025 full-year figure at $286000.0, up 37.5% from the prior year.
- Prepaid Assets for Q1 2026 stood at $467000.0, up from $286000.0 in the prior quarter.
- Over the last five years, Prepaid Assets for NRXP reached as high as $6.5 million in Q2 2022 and fell as low as $128000.0 in Q1 2024.
- Historically, Prepaid Assets has averaged $1.8 million across 5 years, with a median of $1.1 million in 2023.
- Across the five-year window, Prepaid Assets surged 26282.17% in 2022 and slumped 96.07% in 2024, its largest moves.
- Year by year, Prepaid Assets stood at $331000.0 in 2022, then jumped by 225.68% to $1.1 million in 2023, then slumped by 80.71% to $208000.0 in 2024, then soared by 37.5% to $286000.0 in 2025, then soared by 63.29% to $467000.0 in 2026.
- Per Business Quant data, the three most recent Prepaid Assets figures were $467000.0 in Q1 2026, $286000.0 in Q4 2025, and $335000.0 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | NRX Pharmaceuticals | 137.57 Mn | 130.87 Mn | 437,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 467,000.00 |
| Dec 31, 2025 | 286,000.00 |
| Sep 30, 2025 | 335,000.00 |
| Jun 30, 2025 | 1.68 Mn |
| Mar 31, 2025 | 1.71 Mn |
| Dec 31, 2024 | 208,000.00 |
| Sep 30, 2024 | 421,000.00 |
| Jun 30, 2024 | 646,000.00 |
| Mar 31, 2024 | 128,000.00 |
| Dec 31, 2023 | 1.08 Mn |
| Sep 30, 2023 | 4.19 Mn |
| Jun 30, 2023 | 2.02 Mn |
| Mar 31, 2023 | 3.25 Mn |
| Dec 31, 2022 | 331,000.00 |
| Sep 30, 2022 | 4.85 Mn |
| Jun 30, 2022 | 6.52 Mn |
| Mar 31, 2022 | 2.07 Mn |
| Dec 31, 2021 | 5.11 Mn |
| Sep 30, 2021 | 6.35 Mn |
| Jun 30, 2021 | 51,642.00 |